Analytical Data
-
Gene name
AFP2
- Application
-
Alternative Names
Cysteine-rich antifungal protein 2 Short name: AFP2 Short name: RAFP2
-
Species
Raphanus sativus
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P30230
-
Expression Region
30-80aa
-
Molecular Weight
21.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AFP2, or alpha-fetoprotein isoform 2, is a variant of the well-known alpha-fetoprotein, a glycoprotein synthesized primarily by the liver and yolk sac during fetal development. Research on AFP2 has gained significant attention due to its potential applications in oncology and immunology. Unlike its counterpart, AFP1, which is often associated with liver cancer and certain fetal disorders, AFP2 emerges as a candidate for diagnostics and therapeutic targets due to its unique structural and functional properties. Studies have indicated that AFP2 can influence tumor progression and immune response, providing insights into tumor microenvironments. Its expression patterns in various cancers suggest a role in tumor marker development, where elevated levels may indicate malignancies. Furthermore, understanding the molecular mechanisms regulating AFP2 could lead to innovative strategies in cancer treatment and immunotherapy, potentially enhancing the efficacy of existing therapies. As researchers delve deeper into the implications of AFP2, it becomes imperative to explore its interactions at the cellular level and its contributions to the physiology of both normal and cancerous tissues, opening new avenues for clinical applications and personalized medicine. The ongoing investigation into AFP2 is crucial for elucidating its role in disease progression and for harnessing its potential in therapeutic interventions.
